EE200300389A - Meetod 20(S)-kamptotetsiini puhastamiseks - Google Patents

Meetod 20(S)-kamptotetsiini puhastamiseks

Info

Publication number
EE200300389A
EE200300389A EEP200300389A EEP200300389A EE200300389A EE 200300389 A EE200300389 A EE 200300389A EE P200300389 A EEP200300389 A EE P200300389A EE P200300389 A EEP200300389 A EE P200300389A EE 200300389 A EE200300389 A EE 200300389A
Authority
EE
Estonia
Prior art keywords
camptothecin
mixture
crystals
purification
hydrogenating
Prior art date
Application number
EEP200300389A
Other languages
English (en)
Inventor
Sobotta Rainer
Rapp Armin
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300389A publication Critical patent/EE200300389A/et
Publication of EE05131B1 publication Critical patent/EE05131B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EEP200300389A 2001-02-15 2002-02-09 Meetod 20(S)-kamptotetsiini puhastamiseks EE05131B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106969A DE10106969C1 (de) 2001-02-15 2001-02-15 Verfahren zur Reinigung und zur Herstellung von 20(S)-Camptothecin
PCT/EP2002/001375 WO2002064597A2 (de) 2001-02-15 2002-02-09 Verfahren zur reinigung von 20(s)-camptothecin

Publications (2)

Publication Number Publication Date
EE200300389A true EE200300389A (et) 2003-12-15
EE05131B1 EE05131B1 (et) 2009-02-16

Family

ID=7674093

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300389A EE05131B1 (et) 2001-02-15 2002-02-09 Meetod 20(S)-kamptotetsiini puhastamiseks

Country Status (27)

Country Link
EP (1) EP1362051B1 (et)
JP (1) JP4467884B2 (et)
KR (1) KR100813087B1 (et)
CN (1) CN1228340C (et)
AT (1) ATE301124T1 (et)
AU (1) AU2002244711B2 (et)
BG (1) BG108064A (et)
BR (1) BR0207261A (et)
CA (1) CA2435372C (et)
CZ (1) CZ300671B6 (et)
DE (2) DE10106969C1 (et)
EA (1) EA005618B1 (et)
EE (1) EE05131B1 (et)
ES (1) ES2246389T3 (et)
HK (1) HK1064092A1 (et)
HR (1) HRP20030654A2 (et)
HU (1) HUP0303030A3 (et)
IL (2) IL157148A0 (et)
MX (1) MXPA03007194A (et)
NO (1) NO328106B1 (et)
NZ (1) NZ528039A (et)
PL (1) PL202135B1 (et)
RS (1) RS50496B (et)
SK (1) SK10192003A3 (et)
UA (1) UA74874C2 (et)
WO (1) WO2002064597A2 (et)
ZA (1) ZA200305364B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396690B (zh) * 2006-04-27 2013-05-21 Yakult Honsha Kk 喜樹鹼衍生物的製造方法
WO2009145282A1 (ja) * 2008-05-29 2009-12-03 メルシャン株式会社 カンプトテシン誘導体の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds

Also Published As

Publication number Publication date
CA2435372C (en) 2010-04-20
NO328106B1 (no) 2009-12-07
NZ528039A (en) 2006-02-24
EA005618B1 (ru) 2005-04-28
EE05131B1 (et) 2009-02-16
BR0207261A (pt) 2004-06-15
CA2435372A1 (en) 2002-08-22
EA200300837A1 (ru) 2003-12-25
CZ20032211A3 (cs) 2003-12-17
IL157148A0 (en) 2004-02-08
CZ300671B6 (cs) 2009-07-15
PL202135B1 (pl) 2009-06-30
HUP0303030A2 (hu) 2003-12-29
WO2002064597A3 (de) 2002-10-24
HUP0303030A3 (en) 2004-11-29
EP1362051B1 (de) 2005-08-03
SK10192003A3 (sk) 2004-01-08
KR100813087B1 (ko) 2008-03-17
IL157148A (en) 2008-08-07
ES2246389T3 (es) 2006-02-16
CN1491228A (zh) 2004-04-21
DE50203824D1 (de) 2005-09-08
HK1064092A1 (en) 2005-01-21
JP2004521909A (ja) 2004-07-22
NO20033614D0 (no) 2003-08-14
ATE301124T1 (de) 2005-08-15
BG108064A (bg) 2005-04-30
KR20030076674A (ko) 2003-09-26
DE10106969C1 (de) 2002-10-02
UA74874C2 (en) 2006-02-15
AU2002244711B2 (en) 2007-05-31
MXPA03007194A (es) 2003-12-04
CN1228340C (zh) 2005-11-23
NO20033614L (no) 2003-08-14
PL362128A1 (en) 2004-10-18
RS50496B (sr) 2010-03-02
ZA200305364B (en) 2004-04-28
WO2002064597A2 (de) 2002-08-22
JP4467884B2 (ja) 2010-05-26
YU61403A (sh) 2006-05-25
EP1362051A2 (de) 2003-11-19
HRP20030654A2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
DE60332776D1 (de) Herstellung von Delta-9-Tetrahydrocannabinol
EA200500703A1 (ru) Новые трициклические соединения для лечения воспалительных и аллергических нарушений, способ их приготовления и содержащие их фармацевтические составы
EA200200590A1 (ru) Производные пирролидина в качестве ингибиторов фосфодиэстеразы, специфичной к циклическому амф
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE368689T1 (de) Neodymium-carboxylatederivate und ihre verwendung für die polymerisation von konjugierten dienen
AU2002243644A1 (en) Novel methods and blends for controlling rehology and transition temperature of liquid crystals
RS101403A (en) Process for the preparation of racemic citalopram and/or s or r-citalopram by separation of a mixture of r-and s- citalopram
ATE494271T1 (de) Verfahren zur reinigung und aufkonzentrierung von distickstoffmonoxid
NO20062656L (no) Fremgangsmate for fremstilling av statiner
GR20010100097A (el) Μεθοδος παρασκευης της σιταλοπραμης
MY142239A (en) Alkene separation process
WO2003028665A3 (en) Methods for the purification of levofloxacin
EA200400195A1 (ru) Способ репродукции вируса
EE05131B1 (et) Meetod 20(S)-kamptotetsiini puhastamiseks
ATE363469T1 (de) Verfahren zur herstellung von 1,4-dihydropyridin- intermediate und deren derivate
WO2003045329A3 (en) Methods for the purification of levofloxacin
WO2002059127A3 (en) Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
ATE306479T1 (de) Verfahren zur herstellung von flavon derivaten
MXPA05009764A (es) Metodo para producir 2-ciano-3-hidroxi-n-(fenil)but-2-enamidas.
ATE380190T1 (de) Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen
ATE377587T1 (de) Verfahren zur herstellung von pyridin und picolinen
Guravaiah et al. Solvent-free synthesis of new heteryl β-ketosulfones
ATE295350T1 (de) Verfahren zur herstellung von 3 spiro'cyclohexan- 1,3'-'3höindolin-2'-onöderivaten
Yamaguchi et al. Ring Expansion and Ring Contraction Observed in Isopropenyldihydrofuran Derivatives.
ATE387436T1 (de) Verfahren zur herstellung von isoflavonen

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20100209